Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The pressing need for broad-spectrum antivirals could be met by targeting host rather than viral processes. Cholesterol biosynthesis within the infected cell is one promising target for a large number of viral systems, including hepatitis C virus (HCV), hepatitis B virus (HBV) and HIV. Liposomes developed for intracellular, endoplasmic reticulum (ER)-targeted in vivo drug delivery have been modified to include polyunsaturated fatty acids that exert an independent antiviral activity through the reduction of cellular cholesterol. These polyunsaturated ER liposomes (PERLs) have greater activity than lovastatin (Mevacor, Altoprev), which is clinically approved for lowering cholesterol and preventing cardiovascular disease. Treatment of HCV, HBV, and HIV infections with PERLs significantly decreased viral secretion and infectivity, and pretreatment of naïve cells reduced the ability of both HCV and HIV to establish infections because of the decreased levels of plasma membrane cholesterol. Direct competition for cellular receptors was an added effect of PERLs against HCV infections. The greatest antiviral activity in all three systems was the inhibition of viral infectivity through the reduction of virus-associated cholesterol. Our study demonstrates that PERLs are a broadly effective antiviral therapy and should be developed further in combination with encapsulated drug mixtures for enhanced in vivo efficacy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to our HCMV studies, depletion of cholesterol was observed to compromise infectivity of other enveloped viruses, such as HIV-1, hepatitis B and C viruses, and influenza (112–115).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [112]
Citations
Cites
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
The lipid droplet is an important organelle for hepatitis C virus production
Miyanari, Y., Atsuzawa, K., Usuda, N., Watashi, K., Hishiki, T., Zayas, M., Bartenschlager, R., Wakita, T., Hijikata, M., & Shimotohno, K. (2007) · Nature Cell Biology · doi:10.1038/ncb1631 · Cited by 1,249
Nguyen, D. H., & Hildreth, J. E. K. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3264-3272.2000 · Cited by 788
Plasma membrane rafts play a critical role in HIV-1 assembly and release
Ono, A., & Freed, E. O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241320298 · Cited by 706
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
Kapadia, S. B., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409834102 · Cited by 511
Aloia, R. C., Tian, H., & Jensen, F. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5181 · Cited by 440
Statins Inhibit HIV-1 Infection by Down-regulating Rho Activity
del Real, G., Jiménez-Baranda, S., Mira, E., Lacalle, R. A., Lucas, P., Gómez-Moutón, C., Alegret, M., Peña, J. M., Rodríguez-Zapata, M., Alvarez-Mon, M., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040061 · Cited by 294
Lipid rafts and HIV-1: from viral entry to assembly of progeny virions
Campbell, S. M., Crowe, S. M., & Mak, J. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(01)00193-7 · Cited by 281
Shavinskaya, A., Boulant, S., Penin, F., McLauchlan, J., & Bartenschlager, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707329200 · Cited by 275
Boulant, S., Targett-Adams, P., & McLauchlan, J. (2007) · Journal of General Virology · doi:10.1099/vir.0.82898-0 · Cited by 274
Cited by
Broad-spectrum antivirals against viral fusion
Vigant, F., Santos, N. C., & Lee, B. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3475 · Cited by 266
An overview of functional nanoparticles as novel emerging antiviral therapeutic agents
Chen, L., & Liang, J. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2020.110924 · Cited by 255
Gudleski-O'Regan, N., Greco, T. M., Cristea, I. M., & Shenk, T. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.05.012 · Cited by 84
“, 2009), cholesterol is important for replication of a variety of enveloped viruses (Pollock et al., 2010), and HCMV infection alters cholesterol levels (Abrahamsen et al.”
BackgroundThe Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology
Greco, T. M., Diner, B. A., & Cristea, I. M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085527 · Cited by 67
Metadata
- Authors
- Pollock, S., Nichita, N. B., Böhmer, A., Radulescu, C., Dwek, R. A., & Zitzmann, N.
- Affiliations
- University of Oxford (GB)
- Institute of Biochemistry (RO)
- Corresponding author
- Zitzmann, Nicole
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-09-20
- Volume
- 107
- Issue
- 40
- Pages
- 17176-17181
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2951407
- OpenAlex
- W1990048595
- Cited by
- 76
- References
- 27
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 13 · 2020: 9 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 4
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- United Therapeutics Corporation
- Linacre College, University of Oxford
- Universität Heidelberg
- National Institutes of Health
- Canadian Institutes of Health Research
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- cholesterol depletion, host-directed antiviral therapy, hepatitis C virus, hepatitis B virus, HIV, lovastatin, viral infectivity, plasma membrane cholesterol, receptor competition, broad-spectrum antivirals
- MeSH terms
- Antiviral Agents, Cell Line, Cholesterol, Fatty Acids, Unsaturated, Hepatitis B, Hepatitis B virus, HIV, Humans, Liposomes, HIV Infections, Hepacivirus, Hepatitis C, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells. https://app.cochat.ai/papers/10.1073/pnas.1009445107
- The paper
- Pollock, S., Nichita, N. B., Böhmer, A., Radulescu, C., Dwek, R. A., & Zitzmann, N. (2010). Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1009445107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.